129 related articles for article (PubMed ID: 19549465)
21. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.
Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA
HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330
[TBL] [Abstract][Full Text] [Related]
22. Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal.
Alikhani A; Morin H; Matte S; Alikhani P; Tremblay C; Durand M
BMC Infect Dis; 2019 Sep; 19(1):820. PubMed ID: 31533648
[TBL] [Abstract][Full Text] [Related]
23. [Association between the change regularity of peripheral blood mononuclear cell mitochondrial deoxyribonucleic acid content and human immunodeficiency virus-related lipodystrophy].
Wu P; Gu WB; Zhang L; Li YL; Qiu ZF; Han Y; Xie J; Li TS
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1448-52. PubMed ID: 21914278
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and factors associated with the clinical forms of lipoatrophy during highly active antiretroviral therapy in Ouagadougou, Burkina Faso.
Guira O; Tiéno H; Yaméogo B; Diendéré AE; Korsaga N; Sagna Y; Zoungrana L; Diallo I; Traoré R; Drabo JY
J Int Assoc Provid AIDS Care; 2014; 13(2):184-7. PubMed ID: 24114724
[TBL] [Abstract][Full Text] [Related]
25. Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Aurpibul L; Puthanakit T; Lee B; Mangklabruks A; Sirisanthana T; Sirisanthana V
Antivir Ther; 2007; 12(8):1247-54. PubMed ID: 18240864
[TBL] [Abstract][Full Text] [Related]
26. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy.
Johnson JA; Albu JB; Engelson ES; Fried SK; Inada Y; Ionescu G; Kotler DP
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E261-71. PubMed ID: 14532165
[TBL] [Abstract][Full Text] [Related]
27. Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children.
Viganò A; Mora S; Testolin C; Beccio S; Schneider L; Bricalli D; Vanzulli A; Manzoni P; Brambilla P
J Acquir Immune Defic Syndr; 2003 Apr; 32(5):482-9. PubMed ID: 12679698
[TBL] [Abstract][Full Text] [Related]
28. Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen.
Wangsomboonsiri W; Mahasirimongkol S; Chantarangsu S; Kiertiburanakul S; Charoenyingwattana A; Komindr S; Thongnak C; Mushiroda T; Nakamura Y; Chantratita W; Sungkanuparph S
Clin Infect Dis; 2010 Feb; 50(4):597-604. PubMed ID: 20073992
[TBL] [Abstract][Full Text] [Related]
29. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.
Cavalcanti RB; Raboud J; Shen S; Kain KC; Cheung A; Walmsley S
J Infect Dis; 2007 Jun; 195(12):1754-61. PubMed ID: 17492590
[TBL] [Abstract][Full Text] [Related]
30. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women.
Jacobson DL; Knox T; Spiegelman D; Skinner S; Gorbach S; Wanke C
Clin Infect Dis; 2005 Jun; 40(12):1837-45. PubMed ID: 15909274
[TBL] [Abstract][Full Text] [Related]
32. Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz.
Viganò A; Brambilla P; Cafarelli L; Giacomet V; Borgonovo S; Zamproni I; Zuccotti G; Mora S
Antivir Ther; 2007; 12(3):297-302. PubMed ID: 17591019
[TBL] [Abstract][Full Text] [Related]
33. Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy.
Freitas P; Santos AC; Carvalho D; Pereira J; Marques R; Martinez E; Sarmento A; Medina JL
J Clin Densitom; 2010; 13(2):197-203. PubMed ID: 20347364
[TBL] [Abstract][Full Text] [Related]
34. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
[TBL] [Abstract][Full Text] [Related]
35. High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy.
Leclercq P; Goujard C; Duracinsky M; Allaert F; L'henaff M; Hellet M; Meunier JP; Carret S; Thevenon J; Ngo Van P; Pialoux G
AIDS Res Hum Retroviruses; 2013 May; 29(5):761-8. PubMed ID: 23268562
[TBL] [Abstract][Full Text] [Related]
36. Increased mitochondrial DNA content in peripheral blood lymphocytes from HIV-infected patients with lipodystrophy.
Cossarizza A; Riva A; Pinti M; Ammannato S; Fedeli P; Mussini C; Esposito R; Galli M
Antivir Ther; 2003 Aug; 8(4):315-21. PubMed ID: 14518701
[TBL] [Abstract][Full Text] [Related]
37. The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection.
Guaraldi G; Stentarelli C; Zona S; Santoro A; Beghetto B; Carli F; Orlando G; Franceschetto A; Casolo A; Mussini C
HIV Med; 2014 Nov; 15(10):587-94. PubMed ID: 24750806
[TBL] [Abstract][Full Text] [Related]
38. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):688-94. PubMed ID: 12615670
[TBL] [Abstract][Full Text] [Related]
39. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences.
Hammond E; McKinnon E; Nolan D
Clin Infect Dis; 2010 Sep; 51(5):591-9. PubMed ID: 20645860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
